AzTrials
AzTrials

Diabetes Mellitus, Type 2PPD-MaliNCT05260879

Potential Effectiveness of the Diabetes Prevention Program in the Peri-urban Area of Bamako, Mali

A study testing Diabetes prevention program in people with Diabetes Mellitus, Type 2, run by University Clinical Research Center, Mali at 6 sites in Mali.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed research is an innovative adaptation of the Centers for Disease Control and Prevention's (CDC) Diabetes Prevention Program "Power to Prevent" program, which will be developed and piloted in the low-income peri-urban neighborhoods of Bamako, Mali. Read more about this study

Who is it for?
Ages 25 years and older
Conditions the study is for
Diabetes Mellitus, Type 2
What is being tested?
Diabetes prevention program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
440 participants
Where
6 sitesMali
Study dates
26 Nov 2021to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 25 or more
  • Diagnosed with type II diabetes or hypertension or Obesity
  • Willing to commit to participate at biweekly sessions for 6 months

Who cannot join

  • History of stroke or cardiac arrest
  • Gestational diabetes
  • Type I diabetes

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

Mali6 sites
  • ASACOBA

    Bamako

  • Asacodjeneka

    Bamako

  • ASACODOU

    Bamako

  • Asacola B5

    Bamako

  • Asacola Ii

    Bamako

  • Asacosisou

    Bamako

Other trials in Mali

About this study

The proposed research is an innovative adaptation of the Centers for Disease Control and Prevention's (CDC) Diabetes Prevention Program "Power to Prevent" program, which will be developed and piloted in the low-income peri-urban neighborhoods of Bamako, Mali. This program is well-suited to delivery by the city's community health workers already supporting families in improving maternal and child health outcomes. First, it will use participatory research methods to engage them and community residents in making adaptations to the community health worker's guidelines and tools for recommended activities so that they are linguistically and culturally appropriate, including guidelines for food consumption using locally available foods. These adaptations will use more graphics and photographs, so they are appropriate for low-literacy participants. Second, another key innovation is the explicit orientation to couples, where only one may have a diagnosed cardiovascular disease. This adaptation will provide tools the women can use in negotiating for changes to the family's meals and her daily routine. Third, investigators will conduct a comparative effectiveness study at 6 community health centers with high rates of Cardiovascular Disease (CVD), recruiting adults recently diagnosed with diabetes or hypertension. Based on the random allocation of their community health center, participants will be assigned to one of three groups of 150 each: Couples, with at least one meeting the eligibility criteria; Individuals, men and women, both eligible; Comparison, men and women with CVD. Trained community health workers and diabetic peer educators will use the adapted Diabetes Prevention Program (DPP) materials with the Couples and Individuals groups over a period of 6 months. At the conclusion of this pilot investigators will assess the levels of adoption of recommended cardiovascular risk reduction behaviors and changes in obesity, hypertension, and diabetes control, comparing differences in outcomes between the three groups. It will enable Mali to incorporate diabetes and hypertension risk reduction into their already deployed networks of community health workers. The Malian DPP adaptation will also be suitable for Francophone West Africa, where customs and lifestyles are similar among the millions of families confronting the burdens of cardiovascular disease.

Read the detailed description

Specific Aims:

Aim 1 will adapt the diet and lifestyle change modalities of the Small Steps, Big Rewards (SSBR) recommendations to the cultural and economic realities affecting women's choices in Bamako. As in other cross-national adaptations of the DPP, investigators will translate the food and exercise recommendations into equivalent recommendations using locally available foods and exercise opportunities. Study partners have already estimated the caloric and glycemic indices of the most common foods prepared in Mali, and the demonstrations and recommendations will be based on these estimations. Cultural and gender-sensitive recommendations for exercise will be similarly tailored to the urban African context, with participating women from the low-income communities ensuring the cultural appropriateness of these adaptations.

Aim 2 will develop culturally and gender-specific communication strategies for empowering low- income, low-literacy women to apply the SSBR recommendations for themselves and their families. Investigators will incorporate the tools and demonstrations for SSBR developed in Aim 1 to the refinement of the Malian adaptation SSBR-Mali group sessions. An effective approach to chronic disease management in Africa has promoted sharing adherence messages among couples, so they can better support each other in staying adherent. The preliminary work also highlights the need to explore alternative methods to help women gain the approval and support of their spouses and other family members.

Aim 3 is to assess the effectiveness of the Malian adaptation of the DPP to increase adoption of diabetes prevention practices and reduce hyperglycemia and hypertension among couples enrolling in the program, compared to those participating as individuals. Using the adaptation developed in Aim 2 the investigators will compare the effectiveness of the Malian adaptation of the SSBR in selected community health centers in peripheral low-income communities with high rates of diabetes or hypertension. Trained CHWs and diabetic peer educators will implement the program for 6 months, with assessments conducted to compare changes pre-post participation in healthy behaviors and diabetes and hypertension management outcomes with 450 participants in the intervention at 4 community health centers versus 150 comparable individuals at 2 control community centers. The analysis will focus on the comparison of effectiveness for individuals enrolled as couples where at least one has CVD versus those enrolled as individuals with CVD.

Research Plan

  1. Innovation

The couple-orientation to this DPP is innovative, as all previous DPP adaptations focus on individual participants. By enrolling both members of a couple where only one of them may have diabetes or hypertension, they will both participate in group sessions and learn how they can support each other to make changes. Carefully crafted role plays will provide women with the communication tools for negotiating changes to family meals or daily activities. The adaptation will be the first which recognizes the need for materials to be appropriate for low-literacy participants, with greater use of locally prepared photographic and graphic content for group sessions, the CHW flip-chart and participant food and activity tracker materials. The participatory approach to developing the pilot study will further strengthen the skills of the University of Sciences, Techniques and Technologies of Bamako (USTTB) researchers toward shifting their research out of the clinics and into the neighborhoods, enabling them to better partner with the health ministry as they move in the direction of prevention and community-based health services.

  1. Approach
  2. Study Site: Mali has noncommunicable diseases mortality rates among the highest in the world and higher for women than men. In 2019, the number of adults with diabetes was estimated at 157,600 adults, with only 50,000 aware of their diabetes. Bamako, the capital city with over 2 million residents, has the highest obesity and cardiovascular disease rates. Over one in ten urban adults are diabetic, and one in four hypertensive. Between 2002 and 2013 obesity among city residents aged 15-65 rose from 10% to 16%, with obesity rates five times higher for women than men. The rates of obesity and malnutrition (low diet diversity) were higher among the less educated and in low-income, peripheral neighborhoods. Therefore, this pilot study will focus on the low-income peripheral neighborhoods of Communes I and IV, where the investigators will select the six Community Health Centers (CSCOM), Mali's primary health care centers, with the highest numbers of diabetes and hypertension diagnoses in the previous two years. Four will be randomly selected to participate in the pilot, while two will serve as comparison sites.
  3. Research Strategy The adaptation of the DPP SSBR program will adhere to the principles of the trans-theoretical model for facilitating behavioral change to resistant behaviors. The group lifestyle behavior approach of the DPP program is already based on the principles of the trans-theoretical change model, with the sessions helping people move quickly from pre-contemplation to contemplation (Sessions 1 and 2), preparation (Sessions 3-6), with adoption the focus of sessions 4-9, and maintenance the focus of sessions 10-12. The role plays, demonstrations, and discussions are designed to build the confidence of women to introduce healthy eating and lifestyles to their husbands and other women in their household. To ensure that the tools and activities are appropriate for the Bamako context, participatory research methods will be used, inviting 30 community residents (12 women, 12 men and 6 CHWs) from the a CSCOM to participate in the adaptation process.

To make the sessions more culturally appropriate, including the importance of involving the other women in the household in food and cooking decisions, the investigators have added sessions on how to share the responsibility for a healthy lifestyle with the other women in the household, as well as how to gain the support of the household head and other family and friends. The sessions on eating out and reading labels have been modified to be appropriate for the types of street food and market products available in Bamako. The sessions on caloric balance have been converted to the balance in the number of portions, with an emphasis on measuring portions and ingredients used in cooking. Role plays, demonstrations, and videos of exercises have been included, complementing the group discussions already included in the DPP group approach format. With these additions the number of sessions is 15, similar to that used in other group lifestyle adaptations of the DPP Power to Prevent. The training tools were pre-tested with the community health workers of a CSCOM in Bamako, and then finalized during the training of the community health workers who will deliver the program.

After the SSBR-M sessions and tools are developed, a pilot study will be conducted to assess the potential contribution that participation might make to changes in recommended behaviors of the participants and their spouses, as well as to their level of blood sugar, blood pressure, BMI and waist circumference.

Being tested
Diabetes prevention program
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diabetes prevention programBehavioural

    Also called PPD-Mali

    Adaptation of the Centers for Disease Control and Prevention (CDC) Diabetes Prevention Program Power to Prevent for use in low income neighborhoods in Bamako, Mali

Study groups in NCT05260879
Study groupRoleWhat they receive
IndividualsExperimentalThis arm is composed of diabetic or hypertensive men and women who participate without joint participation of their spouse. The intervention consists of exposing participants to bi-monthly educational sessions on diet and exercise. Participants will be organized in groups of 15 led by one community health worker (CHW) assisted by a diabetes peer educator (PE). The basic format for the group sessions will follow the pattern developed with the DPP program, beginning with a discussion of "success" stories from the past weeks before proceeding to the didactic portion of the session. The sessions will mix the didactic portions facilitated by the PE with group discussions, activities and role plays, facilitated by the CHW.
Receives: Behavioral: Diabetes prevention program
CouplesExperimentalWomen recruited for the couples group will be asked to invite their husbands to participate, regardless of their husband's CVD status, and men whose wives do not have CVD similarly will be asked to enroll with their wife. The intervention consists in exposing them to bi-monthly educational sessions on diet and exercise. The intervention consists in exposing participants with bi-monthly educational sessions on diet and exercise. Participants will be organized in groups of 15 to 30, led by one community health worker (CHW) assisted by a diabetes peer educator (PE). The basic format for the group sessions will follow the pattern developed with the DPP program, beginning with a discussion of "success" stories from the past weeks before proceeding to the didactic portion of the session. The sessions will mix the didactic portions facilitated by the PE with group discussions, activities and role plays, facilitated by the CHW.
Receives: Behavioral: Diabetes prevention program
ComparisonNo interventionThe comparison group is composed of diabetic or hypertensive individuals who agreed to participate in the study but who will not be exposed to the sessions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adoption of the recommended diet and exercise behavior

    Number of participant who adopt the DPP recommended diet and exercise behavior

    Measured: Month 0 to Month 6

Secondary outcomes (3)
  1. Reduction in Body Mass Index (BMI)

    Number of participants with reduced BMI (Weight in Kg/Height in cm) will be combined to report in kg/cm sq x10,000

    Measured: Month 0 to Month 6

  2. Reduction in number of participants with Hypertension

    Hypertension (>=140 Systole (SS) /90Diastol)

    Measured: Month 0 to Month 6

  3. Reduction in number of participants with hyperglycemia

    Hyperglycemia (>= 8.0 HbA1c)

    Measured: Month 0 to Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2022
  2. Study start26 Nov 2021
  3. Primary completion28 Jun 2022
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
440 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05260879
Sponsor's protocol ID
2020/207/CE/FMOS/FAPH
Other IDs
1R21TW011736-01
Acronym
PPD-Mali
Status last verified
Dec 2023
First submitted
6 Dec 2021
Last updated
27 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Findley SE, Doumbia L, Ba HO, Maiga B, Berethe RK, Sangare HM, Besancon S, Coumare D, Coulibaly L, Cisse H, Sidibe SY, Diallo K, M'Baye R, Simaga M, Coumare M, Goita A, Diarra B, Kante M, Sanogo F, Sarro YDS, Boukenem L, Sylla SD, Nientao I, Sangho H, Kachur SP, Doumbia S. A Hybrid Effectiveness-Implementation Trial of the 'Power To Prevent Diabetes Program' in Bamako, Mali. Glob Implement Res Appl. 2026 Jan 8:10.1007/s43477-025-00199-x. doi: 10.1007/s43477-025-00199-x. Online ahead of print.

    PubMed 41647680

Questions about this trial

What is this clinical trial studying?

A study testing Diabetes prevention program in people with Diabetes Mellitus, Type 2, run by University Clinical Research Center, Mali at 6 sites in Mali.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Mali. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adoption of the recommended diet and exercise behavior (time frame: Month 0 to Month 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05260879, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in